Citadel Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
VPM
VCM
Citadel Advisors's PBH Position: Q1 2026 in Review
Citadel Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 25% in Q1 2026, selling an estimated $3.91M and leaving 183,440 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3136.
Citadel Advisors first reported a position in PBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $15M in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.
- Citadel Advisors held 183,440 shares of Prestige Consumer Healthcare worth $10.9M as of Q1 2026.
- Citadel Advisors sold 60,221 Prestige Consumer Healthcare shares in Q1 2026, an estimated $3.91M.
- Prestige Consumer Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3136 holding.
- Citadel Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Prestige Consumer Healthcare position peaked at $15M in Q4 2025.
- 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.